Pure Global
Registrant profile

Wuhan Changli BIOTECH Co., Ltd.

武汉市长立生物技术有限责任公司
Hubei·China NMPA·141 registered devices
141
Total devices
1
Device classes
2019
Earliest approval
2025
Latest approval
Company overview
Total devices
141
Province/Region
Hubei
湖北
Address
Room 01, 3rd floor, 4th floor, No. 388, Gaoxin 2nd Road, Wuhan Optics Valley International Biomedical Enterprise Accelerator, Phase 1.1, Phase 10, East Lake New Technology Development Zone, Wuhan
武汉市东湖新技术开发区高新二路388号武汉光谷国际生物医药企业加速器1.1期10栋3层01室、4层01室
Registration timeline
Earliest approval
Jul 10, 2019
Latest approval
Jan 26, 2025
Device class distribution
Breakdown of 141 devices by regulatory classification
Class II
141
100.0% of total
Registered devices (10 most recent shown)
Click on any device for detailed registration information
Product nameClassRegistration numberApproval dateExpiry dateDetail
亮氨酸氨基肽酶测定试剂盒（L-亮氨酸-P-硝基苯胺底物法）
Class II鄂械注准20252405404Jan 26, 2025Jan 25, 2030View
Homocysteine ​​Detection Reagent Kit (Circulating Enzyme Method)
同型半胱氨酸测定试剂盒（循环酶法）
Class II鄂械注准20252405377Jan 21, 2025Jan 20, 2030View
Direct bilirubin assay kit (vanadate oxidation)
直接胆红素测定试剂盒（钒酸盐氧化法）
Class II鄂械注准20252405368Jan 17, 2025Jan 16, 2030View
Complement C3 assay kit (immunotransmission turbidimetry method)
补体C3测定试剂盒（免疫透射比浊法）
Class II鄂械注准20242405277Nov 25, 2024Nov 24, 2029View
Complement C4 detection reagent kit (immunoturbidimetry)
补体C4测定试剂盒（免疫透射比浊法）
Class II鄂械注准20242405278Nov 25, 2024Nov 24, 2029View
Immunoglobulin M detection kit (immunotransmission turbidimetry method)
免疫球蛋白M测定试剂盒（免疫透射比浊法）
Class II鄂械注准20242405254Nov 11, 2024Nov 10, 2029View
Immunoglobulin A Test Kit (Immunotransmission Turbidimetry Method)
免疫球蛋白A测定试剂盒（免疫透射比浊法）
Class II鄂械注准20242405253Nov 11, 2024Nov 10, 2029View
Cystatin C Determination Reagent Kit (Latex-Enhanced Immune Transmission Turbidimetric Method)
胱抑素C测定试剂盒（胶乳增强免疫透射比浊法）
Class II鄂械注准20242405255Nov 11, 2024Nov 10, 2029View
肌酸激酶MB型同工酶(CK-MB)质控品
肌酸激酶MB型同工酶（CK-MB）质控品
Class II鄂械注准20242405183Sep 14, 2024Sep 13, 2029View
Multiple Biochemical Quality Control
多项生化质控品
Class II鄂械注准20242405181Sep 14, 2024Sep 13, 2029View
About this profile

Complete regulatory portfolio for Wuhan Changli BIOTECH Co., Ltd. in China's medical device market. This registrant has 141 medical devices registered with China NMPA, with registrations dating from Jul 10, 2019 to Jan 26, 2025.

Browse the complete device portfolio including device classifications, registration numbers, approval dates, and technical specifications. Pure Global AI provides free access to comprehensive China NMPA registration data, helping global MedTech companies analyze market presence and regulatory compliance for Chinese medical device manufacturers.